BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2119091)

  • 1. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
    Heitz J; Semsch B; Emde C; Jansen U; Schäfer JH
    Z Gastroenterol; 1990 Apr; 28(4):192-7. PubMed ID: 2119091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
    Freise J; Melzer P; Schmidt FW; Horbach L
    Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis.
    Izquierdo R; Sandberg L; Squillaci G; Hoppensteadt D; Walenga J; Fareed J; Prinz R
    Am Surg; 1984 Jun; 50(6):317-23. PubMed ID: 6203448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
    Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
    Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis.
    Chen CC; Wang SS; Tsay SH; Lee FY; Lu RH; Chang FY; Lee SD
    Cytokine; 2006 Jan; 33(2):95-9. PubMed ID: 16473521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
    Dabrowski A; Gabryelewicz A
    J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of the synthetic proteinase inhibitor, FOY, on hypercoagulability after surgery for esophageal carcinoma].
    Usuba A; Motoki R; Koizumi Y; Oishi A; Endo Y; Konno O; Inoue H
    Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):931-41. PubMed ID: 2122227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic antiproteases in acute pancreatitis: an experimental study.
    Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z
    Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination?
    Pezzilli R; Gabbrielli A; Labate AM; D'Alessio P; Barakat B; Costamagna G; Dibenedetti F; Massa M; Merlini G; d'Eril GM
    Hepatogastroenterology; 2003; 50(51):851-5. PubMed ID: 12828103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction.
    Chen HM; Chen JC; Hwang TL; Jan YY; Chen MF
    Hepatogastroenterology; 2000; 47(34):1147-50. PubMed ID: 11020900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
    Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
    J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
    Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY
    J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS).
    Mellgren K; Skogby M; Friberg LG; Tengborn L; Wadenvik H
    Thromb Haemost; 1998 Feb; 79(2):342-7. PubMed ID: 9493588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabexate mesilate improves pancreatic microcirculation and reduces lung edema in a rat model of acute pancreatitis.
    Chen HM; Shyr MH; Chen MF
    J Formos Med Assoc; 1997 Sep; 96(9):704-9. PubMed ID: 9308324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
    Freise J; Schmidt FW; Magerstedt P; Schmid K
    Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs.
    Wakayama T; Itoh T; Shibayama K; Idezuki Y
    Am J Gastroenterol; 1989 Mar; 84(3):272-8. PubMed ID: 2465686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal anticoagulation using a serine protease inhibitor in hemodialysis in sheep.
    Mottaghy K; Oedekoven B; Bey R; Schmid-Schönbein H
    Trans Am Soc Artif Intern Organs; 1985; 31():534-6. PubMed ID: 3939276
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection.
    Shimada M; Matsumata T; Shirabe K; Kamakura T; Taketomi A; Sugimachi K
    J Am Coll Surg; 1994 May; 178(5):498-502. PubMed ID: 8167888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal cases of gabexate mesilate-induced anaphylaxis.
    Matsukawa Y; Nishinarita S; Sawada S; Horie T
    Int J Clin Pharmacol Res; 2002; 22(3-4):81-3. PubMed ID: 12837044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.